A Fox News article recently quoted RemedyOne EVP of clinical services Rob Louie on xylazine, a potent veterinary drug that has seen a recent uptick in illicit human use. Rob helped add context to an alert from the U.S. Drug Enforcement Administration on xylazine. Below is the complete interview, which Rob prepared for in collaboration …
Hemgenix became the most expensive drug in the history of FDA-approvals back in November of 2022 after the manufacturer, CSL Behring, hung a $3.5 million dollar price tag on it. This was a first-of-its-kind therapy approved for the treatment of hemophilia, more specifically hemophilia B. Hemgenix is one of the newest agents utilizing gene therapy …
Hemophilia Gene Therapies: Are the World’s Most Expensive Drugs Really Worth It? Read More »
This might come as a surprise to some individuals as they dive into the listed ingredients of the newest FDA-approved anti-depressant to hit the market, Auvelity. Let’s take a look at this new product and how a cough medicine found its way into this new treatment. Auvelity is a combination product that contains dextromethorphan (yes, …
What Is a Cough Medicine Doing in My Anti-depressant? Read More »
The industry report you’ve been waiting for. Today biosimilars seem to be the topic of conversation everywhere. Why? Humira. The launch of Humira biosimilars will be a test for industry stakeholders, as their entrance will reveal whether blockbuster drugs—that offer significant rebates—can be replaced to reduce the cost burden on patients and payers in the United States. Download our …
Whitepaper: Breaking Down the Hottest Topic in Pharmacy—Humira Biosimilars Read More »
As industry experts, it’s the number one topic we’re being asked to comment on. While biosimilars have existed for many years, the topic has been gaining some serious new attention as AbbVie’s Humira—the number one selling drug in the U.S.—no longer has exclusivity in the market. Will biosimilar competitors increase competition, lower drug costs and …
Healthline recently asked me to provide context for an article about recent research showing that talarozole may reduce and modify the symptoms of osteoarthritis, a condition that impacts more than 32 million American adults. Talarozole was developed in the early 2000s and is currently not licensed or approved to treat any condition. A team at …
Study Shows Talarozole May Help Osteoarthritis Patients Read More »
See this article by RemedyOne clinical pharmacist, Jason Peterson, R.Ph. as it originally appeared in Pharmaphorum. People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment. The milder form of narcolepsy includes symptoms of excessive daytime sleepiness and can be treated with a stimulant …
Competition is on the Horizon for Costly Narcolepsy Treatments Read More »
RemedyOne EVP of clinical services Robert Louie recently published an article for Pharmaphorum about topical psoriasis treatments Vtama and Zoryve. Below is an excerpt. Psoriasis is a tricky disease to manage, as drawbacks and side effects loom with each and every type of treatment. Anyone who watches television has heard the list of potential adverse …
It’s Been a Long Time Coming for Long-Term Topical Psoriasis Treatments Read More »
Amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig’s Disease, is a rare, progressive, neurodegenerative disorder that affects nerve cells in the spinal cord and the brain. These motor neurons govern voluntary movement and muscle control. ALS causes motor neurons to degenerate and eventually die, resulting in muscle weakness, disability and eventually death. The …
An article on Health.com recently quoted me about an exciting new FDA-approved drug shown to extend metastatic breast cancer patients’ lives significantly. Enhertu is a combination of two known therapies, trastuzumab and deruxtecan work in tandem to target the lower levels of HER2 proteins present. As I described in the article, these two therapies work …
Terms of Use | Privacy Policy | All trademarks herein are registered trademarks of their respective owners. | ©2020 RemedyOne | All rights reserved.
